Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.390
-0.060 (-4.14%)
At close: Jul 15, 2025, 4:00 PM
1.410
+0.020 (1.44%)
After-hours: Jul 15, 2025, 4:14 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $85.33 million as of July 15, 2025. Its market cap has decreased by -86.63% in one year.
Market Cap
85.33M
Enterprise Value
-160.14M
1-Year Change
-86.63%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $85.33M, a decrease of -88.43%. That is a compound annual growth rate of -34.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 89.01M | -88.89% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 222.35B |